Skip to main content
. 2021 Nov 2;12:734986. doi: 10.3389/fpsyt.2021.734986

Table 1.

Demographics, pain characteristics and recalled expectation rates (RE)*.

N* RE** P value
Gender M 21 (35%) 7.95, 2.08 0.720
F 39 (65%) 7.72, 2.62
Associated pain related diseases Healthy 22 (38.6%) 7.45, 2.59 0.860
Pain related diseases 10 (17.5%) 7.90, 2.92
Other 25 (43.6%) 8.00, 2.24
Laterality Unilateral 33 (57.9%) 8.21, 2.38 0.046
Bilateral 24 (42.1%) 7.08, 2.44
Temporal pain characteristics Attacks 17 (29.3%) 8.12, 2.59 0.740
Constant 25 (43.1%) 7.52, 2.55
Both 16 (27.6%) 7.75, 2.23
Pain wake from sleep No 35 (60.3%) 7.60, 2.56 0.240
Yes 23 (39.7%) 8.35, 2.03
Pain relief <50% 36 (70.6%) 7.59, 0.49 0.773
≥50 % 15 (29.4%) 7.93, 0.54
Quality Burning Yes 12 (20.7%) 6.08, 3.39 0.007
No 46 (79.3%) 8.2, 1.96
Electrical Yes 7 (12.1%) 9, 1.29 0.154
No 51 (87.9%) 7.59, 2.53
Stabbing Yes 18 (31%) 8.17, 1.85 0.399
No 40 (69%) 7.58, 2.67
Throbbing Yes 18 (31%) 8.0, 2.44 0.620
No 40 (69%) 7.65, 2.47
Pressure Yes 36 (62.1%) 7.58, 2.30 0.490
No 22 (37.9%) 8.05, 2.70
Diagnosis Migraine or NVOP 21 (35%) 7.67, 2.44 0.387
TMD 16 (26.7%) 8.06, 2.32
PTTN 10 (16.7%) 7.00, 3.20
TN 5 (8.3%) 9.60, 0.89
Other 8 (13.3%) 7.50, 20
Medication type AED 40 (85.1%) 8.05, 2.297 0.605
TCA 3 (6.3%) 7.33, 0.58
SNRI 2 (4.2%) 6.00, 5.66
Abortive 2 (4.2%) 7.00, 2.83

*Absolute numbers and percentages can be smaller than the cohort if answers were missing or ambiguous.

**RE- Recalled expectation rates inquired retrospectively during telephone interview rated from 0 to 10.

NVOP, neurovascular orofacial pain; TMD, temporomandibular disorders; PTTN, post traumatic trigeminal neuropathic pain; TN, trigeminal neuralgia; AED, antiepileptic drugs; TCA, tricyclic antidepressants; SNRI, serotonin norepinephrine inhibitors; Abortive = Mostly NSAIDs. Others - include Atypical, burning mouth syndrome (BMS) and persistent idiopathic facial pain (PIFP).